Kamada Expands US Plasma Operations with Houston Center, Plans FDA Submission
Portfolio Pulse from Benzinga Newsdesk
Kamada Ltd. has expanded its US plasma operations by opening a new plasma collection center in Houston, TX, and plans to submit for FDA approval. The center is expected to significantly increase Kamada's plasma collection capacity and contribute to its revenue growth.
September 23, 2024 | 11:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kamada Ltd. has opened a new plasma collection center in Houston, TX, which will increase its plasma collection capacity and is expected to contribute $8-10 million annually in revenue. The company plans to submit for FDA approval in 2025.
The opening of the new plasma collection center in Houston is a significant development for Kamada, as it expands their collection capacity and is expected to generate substantial revenue. The planned FDA submission indicates a strategic move to secure regulatory approval, which is crucial for operational success.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100